查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1806622

急性復健市场按服务类型、疾病类型、阶段类型、设备类型、患者年龄层、提供者类型和最终用户划分 - 全球预测，2025 年至 2030 年

Acute Rehabilitation Market by Service Type, Disease Type, Phase Type, Device Type, Patient Age Group, Provider Type, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计急性康復市场在 2024 年的价值将达到 551 亿美元，在 2025 年增长至 592.1 亿美元，在 2030 年达到 858.2 亿美元，复合年增长率为 7.66%。

主要市场统计数据
基准年2024年 551亿美元
预计2025年 592.1亿美元
预测年份 2030 858.2亿美元
复合年增长率（%） 7.66%

随着护理模式的演变和对综合急性后解决方案的需求的增长，急性復健领域的创新已准备就绪

近年来，急性復健科已成为连结出院患者和长期功能恢復的关键环节。面临心臟病、神经系统损伤、整形外科手术和慢性肺病的患者越来越多地寻求结构化復健项目，以恢復活动能力、认知功能和整体生活品质。这种日益增长的依赖源于人口结构变化（人口老化推动了对急性后期服务的需求）以及技术进步，这些技术进步使得能够更准确地评估和监测患者病情进展。同时，医疗保健支付者和提供者也逐渐认识到早期疗育策略在降低再入院率和总照护成本方面的价值。因此，急性復健计画正在超越传统的治疗模式，融入数据主导、以患者为中心的方法。

探索透过科技整合、支付改革和以病人为中心的卓越照护重塑急性復原的变革

技术创新对于推动急性復健转型至关重要。利用人工智慧和机器学习的平台正在透过预测患者病情进展并提前预警併发症来扩展临床医生的专业知识。穿戴式装置和远端监控工具正在将护理参与延伸到患者的家庭环境中，提高依从性并实现治疗计划的即时调整。随着这些数位化模式的成熟，电子健康记录和復健管理系统之间的互通性至关重要，这有利于无缝资料交换并促进更全面的护理协调。

评估2025年美国关税对急性復健供应链、服务提供和成本结构的累积影响

2025年将实施的新关税将影响一系列进口復健器械和设备，将对整个供应链和成本结构产生连锁反应。製造商面临机器人、辅助器具和物理治疗设备关键零件进口关税的提高。这些关税的提高促使一些供应商加快在地化策略，寻求国内供应商或签订联合生产协议，以缓解成本压力并确保供应的连续性。

揭示了急性復健在服务类型、疾病类型、阶段类型、设备类型、年龄层、提供者类型和最终用户方面的深刻细分

依服务类型分析，我们发现急性復健生态系虽然支离破碎，但又相互依存。心臟復健计画（包括心血管手术护理和心臟病发作后復健）与专注于活动能力训练、平衡恢復和肌肉调理的门诊物理治疗服务紧密结合。神经復健工作（包括中风和脑外伤復健途径）则利用职业治疗技术和先进的机器人设备来增强神经可塑性。整形外科復健、肺部治疗以及言语和语言介入进一步完善了这个体系，从而实现了无缝衔接的连续护理。

确定影响美洲、欧洲、中东和非洲以及亚太地区医疗保健领域急性復健的关键区域动态

在美洲，急性復健的特点是私人和公共医疗系统高度整合，主要医疗机构大力投资先进的机器人设备和远端医疗平台。美国的卫生政策改革正在推动基于价值的支付方案的采用，奖励早期復健活动和多学科护理团队。在拉丁美洲，数位化应用速度较慢，但该地区正在扩大居家復健服务，以解决地理差异问题。

透过创新、策略伙伴关係和扩大服务组合，分析塑造急性復健未来的关键参与者

急性復健领域的主要企业正透过策略性研发投资和合作伙伴关係推动创新。领先的医疗设备製造商正专注于可适应多种治疗方法的模组化机器人平台。同时，专注于远端医疗的科技公司正与復健服务提供者合作，提供远端监控和虚拟指导解决方案。

为行业领导者提供可行的建议，以利用急性復健趋势并保持在急性后期护理中的竞争优势。

医疗保健提供者应优先采用扩充性的数位平台，以实现远距患者参与和即时数据分析，从而衡量功能改善。这种方法不仅可以增强护理协调，还能强化基于价值的护理提案，并使报销奖励与临床结果保持一致。投资劳动力发展项目可以解决治疗师短缺问题，并培养能够有效运用新技术的多学科团队。

为揭示见解、确保数据完整性和检验急性康復分析结果而采用的严格调查方法的详细信息

本分析以一个强大的研究框架为基础，该框架融合了主要研究方法和次要研究方法。主要研究包括对高级管理人员、临床主任和復健专业人员的深入访谈，以收集新兴挑战和创新驱动力的定性观点。此外，我们还对付款方和医疗服务提供者进行了调查，以评估报销趋势和对技术采用的看法，从而补充了这些见解。

主要结论强调了急性復健领域相关人员的策略要务和未来方向

急性復健领域正处于曲折点。能够有效整合数位健康解决方案和个人化多学科照护模式的机构，有望改善临床疗效并获得有利的报销安排。地理和人口细分为客​​製化服务组合提供了途径，而区域差异则凸显了根据当地监管和经济状况调整策略的重要性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 增加住院復健设施（IRF）以促进专业康復
  • 根据即时患者数据制定​​个人化治疗计划的人工智慧演算法
  • 整合穿戴式感测器的远端復健平台，优化患者活动能力
  • 机器人外骨骼促进中风后急性復健期间的活动能力改善
  • 扩大门诊护理网络减少住院时间和费用
  • 穿戴式生物感测器的出现使得復健期间能够持续监测生理恢復指标
  • 整合虚拟实境模组可增强患者在治疗期间的参与度和依从性
  • 利用远端医疗和远端监控技术开发居家急性復健套件
  • 增加多学科中风復健项目，重点关注认知和功能结果测量
  • 由于老化，术后復健的需求增加

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第八章急性復健市场（依服务类型）

  • 心臟復健
    • 心血管手术后的治疗
    • 心臟病发作后的康復
  • 神经復健
    • 中风復健
    • 创伤性脑损伤康復
  • 职能治疗
  • 整形外科復健
  • 物理治疗
    • 平衡与协调疗法
    • 灵活性训练
    • 肌力和耐力训练
  • 肺康復
  • 语言和听力治疗

第九章急性復健市场（依疾病类型）

  • 心律不整
  • 心绞痛
  • 心房颤动
  • 胆固醇管理
  • 冠状动脉绕道术
  • 冠状动脉疾病或周边动脉疾病
  • 糖尿病
  • 心臟衰竭或移植
  • 高血压
  • 肺动脉高压

第 10 章急性復健市场（依阶段类型）

  • 第一阶段（急性期）
  • 第二阶段（亚急性期）
  • 第三阶段（长期）
  • 第四阶段（重新融入社会）

第 11 章急性復健市场（依设备类型）

  • 认知/音讯设备
  • 行动辅助设备
  • 监控工具
  • 物理治疗设备
  • 机器人设备

第十二章急性復健市场（依患者年龄层）

  • 成人
  • 老年人
  • 孩子们

第十三章急性復健市场（依提供者类型）

  • 家庭康復
  • 医院
  • 住院急性復健中心
  • 门诊復健

第十四章急性復健市场（依最终用户）

  • 政府和公共卫生机构
  • 医疗保健提供者
  • 病人

第 15 章：美洲急性復健市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

16.欧洲、中东和非洲急性復健市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

17.亚太急性復健市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十八章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Acadia Healthcare Company, Inc.
    • Amedisys, Inc.
    • Athena Health Care Systems
    • Aurora Behavioral Health System
    • Cambridge Medical and Rehabilitation Center
    • CareOne Management, LLC by New Frontier Energy, Inc.
    • Covenant Care
    • Ekso Bionics Holdings, Inc.
    • Encompass Health Corporation
    • HCA Healthcare, Inc.
    • LHC Group, Inc. by UnitedHealth Group Incorporated
    • LifePoint Health, Inc.
    • National Healthcare Corporation
    • Nexion Health, Inc.
    • Oceans Healthcare
    • Promises Behavioral Health, LLC
    • St. Ann's Community
    • Tenet Healthcare Corporation
    • The Alden Network
    • The Ensign Group, Inc.
    • Universal Health Services Inc.
    • Genesis Healthcare, Inc.
    • Five Star Senior Living by AlerisLife Inc.
    • ClearSky Health
    • Paradigm Healthcare
    • Select Medical Corporation

第十九章 研究人工智慧

第20章 研究统计

第21章 研究联络人

第22章 研究报导

第23章 附录

Product Code: MRR-0376B2CAB000

The Acute Rehabilitation Market was valued at USD 55.10 billion in 2024 and is projected to grow to USD 59.21 billion in 2025, with a CAGR of 7.66%, reaching USD 85.82 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 55.10 billion
Estimated Year [2025] USD 59.21 billion
Forecast Year [2030] USD 85.82 billion
CAGR (%) 7.66%

Setting the Stage for Acute Rehabilitation Innovation Amid Evolving Care Paradigms and Growing Demand for Integrated Post-Acute Solutions

In recent years, the acute rehabilitation sector has emerged as a critical nexus between hospital discharge and long-term functional recovery. Patients facing cardiac events, neurological injuries, orthopedic procedures, or chronic pulmonary conditions increasingly rely on structured programs to restore mobility, cognitive function, and overall quality of life. This growing reliance has been fueled by demographic shifts, with an aging population driving demand for post-acute services, and technological advances that enable more precise assessment and monitoring of patient progress. In parallel, healthcare payers and providers have recognized the value of early intervention strategies to reduce readmission rates and lower total cost of care. Consequently, acute rehabilitation programs are evolving beyond traditional therapy models to embrace data-driven, patient-centered approaches.

More than ever, the acute rehabilitation landscape is being redefined by the convergence of clinical best practices and digital health innovations. Real-time telemonitoring, wearable sensors, and remote therapy platforms are extending the reach of interventions beyond hospital walls, facilitating continuity of care and enhancing patient engagement. This transformation is further supported by a shift in reimbursement policies that reward outcomes and value-based care, prompting providers to invest in integrated service lines and multidisciplinary teams. Such a holistic approach not only addresses physical impairments but also emphasizes psychosocial support, caregiver education, and home environment modifications to optimize recovery trajectories.

Despite these promising trends, the acute rehabilitation ecosystem faces significant challenges. Variability in care standards, limited access in rural or underserved areas, and resource constraints in post-acute facilities can impede timely initiation of therapy. Providers must also contend with workforce shortages, as the demand for specialized therapists outpaces available training programs. Payers are scrutinizing cost drivers and emphasizing care coordination, introducing performance benchmarks that necessitate robust data analytics capabilities. Simultaneously, patients and caregivers are demanding greater transparency, seamless communication, and personalized care plans that reflect individual goals and lifestyles.

In this executive summary, we embark on an in-depth exploration of the acute rehabilitation sector, examining transformative shifts, policy impacts, segmentation dynamics, regional nuances, and leading industry players. By synthesizing actionable insights and outlining methodological rigor, this report aims to equip stakeholders with a comprehensive understanding of the operating environment and strategic levers for value creation. The subsequent sections will illuminate critical trends, dissect tariff implications, and offer tailored recommendations to drive innovation, enhance patient outcomes, and foster sustainable growth in the evolving acute rehabilitation landscape.

Exploring Transformative Shifts Reshaping Acute Rehabilitation through Technological Integration, Payment Reforms and Patient-Centric Care Excellence

Technological innovation has been the lodestar guiding the transformation of acute rehabilitation. Platforms leveraging artificial intelligence and machine learning are now augmenting clinician expertise by delivering predictive insights into patient progress, flagging risks of complications before they emerge. Wearable devices and remote monitoring tools have extended therapeutic engagement into the patient's home environment, fostering adherence and enabling real-time adjustments to therapy plans. As these digital modalities mature, interoperability across electronic health records and rehabilitation management systems is becoming paramount, facilitating seamless data exchange and fostering more holistic care coordination.

Payment reforms and evolving reimbursement landscapes represent another pivotal shift. Traditional fee-for-service models are increasingly supplanted by value-based arrangements that reward measurable outcomes and penalize avoidable readmissions. This paradigm incentivizes providers to streamline care pathways, optimize resource allocation, and demonstrate efficacy through quantifiable metrics. Early adopters of bundled payment systems and accountable care contracts are already witnessing reductions in overall episode costs while preserving or enhancing patient functional gains.

Concurrently, there has been a decisive move toward patient-centric care excellence. The integration of behavioral health support, caregiver education, and community reintegration planning has broadened the scope of acute rehabilitation beyond pure physical therapy. Collaborative care models now incorporate social determinants of health assessments to tailor interventions that address factors such as housing stability, nutrition, and mental well-being. This holistic construct not only expedites recovery but also mitigates the risk of secondary complications.

Finally, strategic partnerships and consolidation trends are reshaping the competitive landscape. Healthcare systems, specialized rehabilitation providers, and technology vendors are forging alliances to deliver end-to-end solutions. These collaborations aim to combine clinical expertise with digital health platforms, creating ecosystems that support seamless transitions of care. As the sector continues to evolve, stakeholders who can align these multifaceted shifts into cohesive strategies will secure leadership positions in the acute rehabilitation market.

Assessing the Cumulative Impact of United States Tariffs in 2025 on Acute Rehabilitation Supply Chains, Service Delivery and Cost Structures

The introduction of new tariffs in 2025 affecting a range of imported rehabilitation equipment and devices has reverberated across supply chains and cost structures. Manufacturers have faced import duty increases on critical components used in robotics, mobility aids, and physiotherapy equipment. These levies have prompted some providers to accelerate localization strategies, seeking domestic suppliers or entering co-manufacturing agreements to mitigate cost pressures and ensure supply continuity.

Service delivery models have also adapted in response to tariff-driven cost escalations. Providers are exploring alternative sourcing channels and bulk procurement arrangements to spread financial burdens. In certain regions, acute rehabilitation operators have adjusted pricing models, rebalancing between bundled service fees and itemized billing for specialized equipment usage. These adjustments necessitate transparent communication with payers to sustain reimbursement rates aligned with rising input costs.

Moreover, the tariffs have influenced technology adoption timelines. Investments in advanced monitoring tools and robotic devices have been deferred or phased, as stakeholders reevaluate return-on-investment metrics under the new cost paradigm. Simultaneously, there has been renewed interest in lower-cost digital solutions, such as app-based rehabilitation programs and remote coaching platforms, offering more scalable deployment in a tariff-impacted market.

While these shifts have generated short-term financial strain, they have also catalyzed innovation. Collaboration between device manufacturers and rehabilitation providers has intensified to develop modular equipment that can be assembled or upgraded locally. This modularity reduces import dependencies and enhances customization to meet specific patient population needs. As the sector navigates these tariff influences, resilience and agility in supply chain management and strategic procurement practices will be pivotal to sustaining growth and preserving quality of care.

Revealing Insightful Segmentation of Acute Rehabilitation by Service, Disease, Treatment Phases, Device Types, Age Groups, Provider and End User Perspectives

Analysis by service type reveals a fragmented yet interdependent acute rehabilitation ecosystem. Cardiac rehabilitation programs, encompassing post-cardiac surgery therapy and post-heart attack recovery, are tightly integrated with outpatient physical therapy services that focus on mobility training, balance restoration, and strength conditioning. Neurological rehabilitation initiatives, comprising stroke and traumatic brain injury pathways, leverage both occupational therapy techniques and advanced robotic devices to enhance neural plasticity. Orthopedic rehabilitation, pulmonary therapy, and speech and language interventions further complement this matrix, enabling a seamless continuum of care.

When viewed through the lens of disease type, the acute rehabilitation market addresses conditions ranging from abnormal heart rhythms and atrial fibrillation to coronary artery bypass surgery aftercare. Management of high blood pressure and pulmonary hypertension often overlaps with diabetes education and heart failure transplant coordination, resulting in multidisciplinary programs that span clinical boundaries. By aligning therapeutic regimens with specific disease profiles, providers can deliver more personalized interventions that accelerate recovery while reducing resource duplication.

Phase-based segmentation underscores the evolving needs of patients. The acute or Phase I setting prioritizes stabilization and early mobilization immediately post-injury or surgery. Phase II transitions to sub-acute facilities or outpatient centers, focusing on progressive strength and endurance training. Phase III long-term care emphasizes community reintegration, while Phase IV targets full social and vocational return, often utilizing remote monitoring tools and telehealth touchpoints to sustain engagement.

Device type perspectives highlight the critical role of equipment in optimizing therapeutic outcomes. Cognitive and speech devices support neurological patients, whereas mobility devices and robotic platforms empower orthopedic and cardiac cohorts. Monitoring tools and physiotherapy equipment provide real-time feedback, enabling therapists to adjust interventions dynamically. This convergence of hardware underpins the precision of modern rehabilitation programs.

Patient demographics and provider formats further delineate service delivery. Adult, geriatric, and pediatric populations each present unique rehabilitation trajectories, prompting providers to tailor protocols accordingly. Settings range from home-based rehabilitation to hospitals, inpatient acute rehabilitation centers, and outpatient clinics, each offering distinct advantages in terms of intensity, accessibility, and cost structure. Finally, end users-spanning government and public health agencies, healthcare institutions, and directly engaged patients-interact with these segmented offerings to align clinical goals with budgetary and policy imperatives.

Illuminating Key Regional Dynamics Impacting Acute Rehabilitation across the Americas, Europe Middle East Africa and Asia Pacific Healthcare Landscapes

Across the Americas, acute rehabilitation is characterized by robust integration of private and public healthcare systems, where leading providers heavily invest in advanced robotic devices and telehealth platforms. Health policy reforms in the United States have driven adoption of value-based payment schemes, incentivizing early mobilization and multidisciplinary care teams. Latin America, while experiencing slower digital penetration, is progressively expanding home-based rehabilitation services to address geographic disparities.

In Europe, the Middle East and Africa region, established healthcare infrastructures in Western Europe showcase comprehensive post-acute networks supported by government reimbursement models. Central and Eastern European markets are witnessing gradual uptake of mobile monitoring tools as regulatory frameworks evolve. In the Middle East and Africa, public-private partnerships are emerging to fund rehabilitation centers that bridge urban-rural gaps, with an emphasis on tackling noncommunicable disease burdens.

The Asia-Pacific landscape is defined by rapid technological adoption and substantial investments in healthcare modernization. Countries like Japan and South Korea lead in integrating robotics and virtual reality therapies into acute settings, whereas India and Southeast Asia are scaling outpatient and home-based services to meet surging demand. Regulatory harmonization efforts and international collaborations are facilitating faster device approvals, fostering market expansion and cross-border knowledge exchange.

Profiling Leading Players Shaping the Future of Acute Rehabilitation through Innovation, Strategic Partnerships and Expanding Service Portfolios

Leading organizations in the acute rehabilitation space are driving innovation through strategic research and development investments and collaborative partnerships. Major medical device manufacturers are focusing on modular robotic platforms that can be adapted for diverse therapy modalities. Simultaneously, technology firms specializing in telehealth are aligning with rehabilitation providers to deliver remote monitoring and virtual coaching solutions.

Several global healthcare systems and specialty chains are optimizing their delivery networks by integrating inpatient, outpatient, and home-based rehabilitation under unified management structures. These vertically aligned models facilitate standardized protocols, centralized data analytics, and consistent quality measures. In parallel, smaller boutique providers are differentiating through niche offerings, such as pediatric neurological rehabilitation programs and geriatric balance training clinics that leverage culturally tailored interventions.

Strategic alliances between device innovators, software developers, and clinical centers of excellence are accelerating the translation of cutting-edge research into practical applications. Joint ventures are increasingly focused on spanning the full continuum of care, from acute phase stabilization to community reintegration, ensuring that patients benefit from seamless transitions and coherent treatment pathways. As competitive pressures intensify, organizations that can harness these collaborative networks to deliver integrated, outcome-driven solutions are poised to outperform in the acute rehabilitation market.

Delivering Actionable Recommendations for Industry Leaders to Capitalize on Acute Rehabilitation Trends and Sustain Competitive Advantage in Post-Acute Care

Providers should prioritize the adoption of scalable digital platforms that enable remote patient engagement and real-time data analytics to measure functional gains. This approach will not only enhance care coordination but also strengthen value-based care propositions, aligning clinical results with reimbursement incentives. Investing in workforce development programs will address therapist shortages and cultivate cross-disciplinary teams capable of deploying emerging technologies effectively.

Supply chain resilience can be fortified by establishing strategic partnerships with domestic component manufacturers and exploring modular equipment designs that reduce import dependencies. Such initiatives will mitigate the financial impacts of tariff fluctuations and ensure continuity of service delivery. Concurrently, negotiating volume-based procurement contracts with device vendors will leverage economies of scale and secure favorable pricing.

To capture regional growth opportunities, organizations should tailor service offerings to local regulatory environments and reimbursement structures. In emerging markets, expanding home-based rehabilitation networks through telehealth and mobile clinics can overcome geographic barriers. In developed markets, deepening integration across acute, sub-acute, and long-term care phases will drive differentiation and foster patient loyalty.

Finally, leaders must cultivate a culture of continuous innovation by fostering collaborations with academic institutions, technology incubators, and policy think tanks. By aligning strategic roadmaps with the latest clinical research and regulatory developments, organizations will be well-positioned to set industry benchmarks, drive superior patient outcomes, and achieve sustainable growth in the competitive acute rehabilitation arena.

Detailing Rigorous Research Methodology Employed to Uncover Insights, Ensure Data Integrity and Validate Findings in Acute Rehabilitation Analysis

This analysis was underpinned by a robust research framework combining primary and secondary methodologies. Primary research involved in-depth interviews with senior executives, clinical directors, and rehabilitation specialists to gather qualitative perspectives on emerging challenges and innovation drivers. These insights were complemented by surveys of payers and provider organizations to gauge sentiment on reimbursement trends and technology adoption.

Secondary research entailed a comprehensive review of peer-reviewed journals, government health policy publications, and industry white papers to validate market dynamics and regulatory shifts. Data triangulation techniques were employed to reconcile disparate data points and ensure consistency across sources. Market mapping and competitive benchmarking exercises were conducted to position key players according to service offerings, geographic presence, and innovation portfolios.

All findings underwent validation through a rigorous review process, engaging subject matter experts in rehabilitation medicine, healthcare economics, and supply chain management. This iterative vetting ensured that conclusions reflect the latest industry standards, best practices, and anticipated policy developments. By integrating qualitative insights with quantitative analysis, the methodology provides a holistic view of the acute rehabilitation sector's trajectory and strategic imperatives.

Synthesizing Critical Conclusions That Highlight the Strategic Imperatives and Future Directions for Stakeholders in the Acute Rehabilitation Sector

The acute rehabilitation sector is at an inflection point, defined by converging technological advances, policy reforms, and shifting patient expectations. Organizations that can effectively integrate digital health solutions with personalized, multidisciplinary care models will elevate clinical outcomes and secure favorable reimbursement arrangements. Geographic and demographic segmentation offers pathways to tailor service portfolios, while regional nuances underscore the importance of adaptive strategies that align with local regulatory and economic contexts.

Navigating tariff impacts requires proactive supply chain strategies and a willingness to explore modular equipment designs and domestic partnerships. Market leaders will be those who anticipate these external pressures and respond with agile procurement and cost management initiatives. Collaboration across the value chain-from device innovators to clinical providers and payers-will catalyze the development of comprehensive rehabilitation ecosystems that support patients from acute stabilization through full community reintegration.

Ultimately, the imperatives for stakeholders center on innovation, resilience, and patient-centered excellence. By embracing data-driven decision-making, fostering strategic alliances, and continuously optimizing care pathways, organizations can seize opportunities for growth and differentiation. This summary provides the foundational insights necessary to chart a forward-looking strategy in the evolving acute rehabilitation landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growth of inpatient rehabilitation facilities (IRFs) for specialized recovery
  • 5.2. Artificial intelligence algorithms personalizing therapy regimens based on real-time patient data
  • 5.3. Tele-rehabilitation platforms integrating wearable sensors to optimize patient mobility
  • 5.4. Robotic exoskeleton adoption accelerating mobility outcomes in post-stroke acute rehab settings
  • 5.5. Expansion of outpatient acute rehabilitation networks reducing hospital length of stay and costs
  • 5.6. Emergence of wearable biosensors enabling continuous monitoring of physiological recovery markers in rehab
  • 5.7. Integration of virtual reality modules enhancing patient engagement and adherence in therapy sessions
  • 5.8. Development of home-based acute rehabilitation kits leveraging telehealth and remote monitoring technologies
  • 5.9. Growth of multidisciplinary stroke recovery programs emphasizing cognitive and functional outcome measures
  • 5.10. Rise in post-surgical rehabilitation demand driven by aging population

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Acute Rehabilitation Market, by Service Type

  • 8.1. Introduction
  • 8.2. Cardiac Rehabilitation
    • 8.2.1. Post Cardiac Surgery Therapy
    • 8.2.2. Post Heart Attack Rehabilitation
  • 8.3. Neurological Rehabilitation
    • 8.3.1. Stroke Rehabilitation
    • 8.3.2. Traumatic Brain Injury Rehabilitation
  • 8.4. Occupational Therapy
  • 8.5. Orthopedic Rehabilitation
  • 8.6. Physical Therapy
    • 8.6.1. Balance and Coordination Therapy
    • 8.6.2. Mobility Training
    • 8.6.3. Strength and Endurance Training
  • 8.7. Pulmonary Rehabilitation
  • 8.8. Speech & Language Therapy

9. Acute Rehabilitation Market, by Disease Type

  • 9.1. Introduction
  • 9.2. Abnormal Heart Rhythms
  • 9.3. Angina
  • 9.4. Atrial Fibrillation
  • 9.5. Cholesterol Management
  • 9.6. Coronary Artery Bypass Surgery
  • 9.7. Coronary or Peripheral Artery Disease
  • 9.8. Diabetes
  • 9.9. Heart Failure or Transplant
  • 9.10. High Blood Pressure
  • 9.11. Pulmonary Hypertension

10. Acute Rehabilitation Market, by Phase Type

  • 10.1. Introduction
  • 10.2. Phase I (Acute)
  • 10.3. Phase II (Sub-acute)
  • 10.4. Phase III (Long-term)
  • 10.5. Phase IV (Reintegration)

11. Acute Rehabilitation Market, by Device Type

  • 11.1. Introduction
  • 11.2. Cognitive/Speech Devices
  • 11.3. Mobility Devices
  • 11.4. Monitoring Tools
  • 11.5. Physio Equipment
  • 11.6. Robotic Devices

12. Acute Rehabilitation Market, by Patient Age Group

  • 12.1. Introduction
  • 12.2. Adults
  • 12.3. Geriatrics
  • 12.4. Pediatrics

13. Acute Rehabilitation Market, by Provider Type

  • 13.1. Introduction
  • 13.2. Home Based Rehabilitation
  • 13.3. Hospitals
  • 13.4. Inpatient Acute Rehabilitation Centers
  • 13.5. Outpatient Rehabilitation

14. Acute Rehabilitation Market, by End User

  • 14.1. Introduction
  • 14.2. Government & Public Health Agencies
  • 14.3. Healthcare Providers
  • 14.4. Patients

15. Americas Acute Rehabilitation Market

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. Argentina

16. Europe, Middle East & Africa Acute Rehabilitation Market

  • 16.1. Introduction
  • 16.2. United Kingdom
  • 16.3. Germany
  • 16.4. France
  • 16.5. Russia
  • 16.6. Italy
  • 16.7. Spain
  • 16.8. United Arab Emirates
  • 16.9. Saudi Arabia
  • 16.10. South Africa
  • 16.11. Denmark
  • 16.12. Netherlands
  • 16.13. Qatar
  • 16.14. Finland
  • 16.15. Sweden
  • 16.16. Nigeria
  • 16.17. Egypt
  • 16.18. Turkey
  • 16.19. Israel
  • 16.20. Norway
  • 16.21. Poland
  • 16.22. Switzerland

17. Asia-Pacific Acute Rehabilitation Market

  • 17.1. Introduction
  • 17.2. China
  • 17.3. India
  • 17.4. Japan
  • 17.5. Australia
  • 17.6. South Korea
  • 17.7. Indonesia
  • 17.8. Thailand
  • 17.9. Philippines
  • 17.10. Malaysia
  • 17.11. Singapore
  • 17.12. Vietnam
  • 17.13. Taiwan

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Acadia Healthcare Company, Inc.
    • 18.3.2. Amedisys, Inc.
    • 18.3.3. Athena Health Care Systems
    • 18.3.4. Aurora Behavioral Health System
    • 18.3.5. Cambridge Medical and Rehabilitation Center
    • 18.3.6. CareOne Management, LLC by New Frontier Energy, Inc.
    • 18.3.7. Covenant Care
    • 18.3.8. Ekso Bionics Holdings, Inc.
    • 18.3.9. Encompass Health Corporation
    • 18.3.10. HCA Healthcare, Inc.
    • 18.3.11. LHC Group, Inc. by UnitedHealth Group Incorporated
    • 18.3.12. LifePoint Health, Inc.
    • 18.3.13. National Healthcare Corporation
    • 18.3.14. Nexion Health, Inc.
    • 18.3.15. Oceans Healthcare
    • 18.3.16. Promises Behavioral Health, LLC
    • 18.3.17. St. Ann's Community
    • 18.3.18. Tenet Healthcare Corporation
    • 18.3.19. The Alden Network
    • 18.3.20. The Ensign Group, Inc.
    • 18.3.21. Universal Health Services Inc.
    • 18.3.22. Genesis Healthcare, Inc.
    • 18.3.23. Five Star Senior Living by AlerisLife Inc.
    • 18.3.24. ClearSky Health
    • 18.3.25. Paradigm Healthcare
    • 18.3.26. Select Medical Corporation

19. ResearchAI

20. ResearchStatistics

21. ResearchContacts

22. ResearchArticles

23. Appendix

LIST OF FIGURES

  • FIGURE 1. ACUTE REHABILITATION MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 22. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. ACUTE REHABILITATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ACUTE REHABILITATION MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 29. ACUTE REHABILITATION MARKET: RESEARCHAI
  • FIGURE 30. ACUTE REHABILITATION MARKET: RESEARCHSTATISTICS
  • FIGURE 31. ACUTE REHABILITATION MARKET: RESEARCHCONTACTS
  • FIGURE 32. ACUTE REHABILITATION MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. ACUTE REHABILITATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST CARDIAC SURGERY THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST CARDIAC SURGERY THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST HEART ATTACK REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST HEART ATTACK REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY TRAUMATIC BRAIN INJURY REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY TRAUMATIC BRAIN INJURY REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ORTHOPEDIC REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ORTHOPEDIC REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY BALANCE AND COORDINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY BALANCE AND COORDINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY TRAINING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STRENGTH AND ENDURANCE TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STRENGTH AND ENDURANCE TRAINING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SPEECH & LANGUAGE THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SPEECH & LANGUAGE THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ABNORMAL HEART RHYTHMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ABNORMAL HEART RHYTHMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ANGINA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ANGINA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CHOLESTEROL MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CHOLESTEROL MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY OR PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY OR PERIPHERAL ARTERY DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEART FAILURE OR TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEART FAILURE OR TRANSPLANT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HIGH BLOOD PRESSURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HIGH BLOOD PRESSURE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE I (ACUTE), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE I (ACUTE), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE II (SUB-ACUTE), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE II (SUB-ACUTE), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE III (LONG-TERM), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE III (LONG-TERM), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE IV (REINTEGRATION), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE IV (REINTEGRATION), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COGNITIVE/SPEECH DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COGNITIVE/SPEECH DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MONITORING TOOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MONITORING TOOLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSIO EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSIO EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ROBOTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ROBOTIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GERIATRICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOME BASED REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOME BASED REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY INPATIENT ACUTE REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY INPATIENT ACUTE REHABILITATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH AGENCIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 131. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 133. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 141. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 142. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 147. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 149. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 161. CANADA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 162. CANADA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 163. CANADA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 164. CANADA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 165. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 166. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 167. CANADA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. CANADA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 169. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 171. CANADA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. CANADA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 173. CANADA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. CANADA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 175. CANADA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. CANADA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 177. CANADA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. CANADA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 181. MEXICO ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 182. MEXICO ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 183. MEXICO ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 184. MEXICO ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 185. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 186. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 187. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 189. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 191. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 195. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. MEXICO ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. MEXICO ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 199. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 201. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 203. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 205. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 206. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 207. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 209. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 211. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 215. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 217. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 219. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 221. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 222. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 223. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 224. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 225. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 226. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 227. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 229. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 231. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 235. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 261. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 265. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 267. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 269. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 281. GERMANY ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. GERMANY ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 283. GERMANY ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 284. GERMANY ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 285. GERMANY ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 286. GERMANY ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 287. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 288. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 289. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 291. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 293. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 295. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 297. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 299. GERMANY ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. GERMANY ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 301. FRANCE ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. FRANCE ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 303. FRANCE ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 304. FRANCE ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 305. FRANCE ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 306. FRANCE ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2025-2030 (USD MILLION)
  • TABLE 307. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 308. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
  • TABLE 309. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 311. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025-2030 (USD MILLION)
  • TABLE 313. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 315. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 316. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 317. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025-2030 (USD MILLION)
  • TABLE 319. FRANCE ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. FRANCE ACUTE REHABILITATION MARKET SIZE, BY END USE